Private Market View

GeneNeer

Shoham, Israel · Founded 2016 · Privately Held (backing)

Last price · $/share
Implied valuation
$14.2M
Total raised
$3.7M
Last round

Key facts

  • GeneNeer’s last known valuation is $14.2M (Jan 2024).
  • It has raised $3.7M; the latest was Later Stage VC ($1.3M) in Apr 2025.
  • Notable investors include JANSZKY, 2b AHEAD Ventures, Tall Grass Ventures.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 3 names
  • ·Watchlist + deal alerts for GeneNeer
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for GeneNeer are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About GeneNeer

Developer of ag-tech software designed to address crop challenges related to climate change. The company's platform utilizes a breakthrough intellectual property-protected technology that allows smart trait activation or expression and facilitates the timing and level of activation of complex plant traits, such as drought tolerance and other climate-related traits, enabling cultivators to respond to weather changes and avoid yield loss.

Sector
Information Technology
HQ
Shoham, Israel
Founded
2016
Employees
8
Ownership
Privately Held (backing)
PA Mark — not yet priced

GeneNeer doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in GeneNeer shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on GeneNeer in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.